Finance

Lists
Why is 3NK down 2.38%?
Dive Deeper
3NK:FRA
Alphamab Oncology
€0.82
-2.38%
(-0.020) 1D
Oct 9, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 3NK...
Open
€0.82
High
€0.82
Low
€0.82
Mkt. cap
7.11B
Avg. vol.
0.00
Volume
0.00
52-wk high
€1.66
52-wk low
€0.70
No. of employees
515
Open
€0.82
High
€0.82
Low
€0.82
Mkt. cap
7.11B
Avg. vol.
0.00
Volume
0.00
52-wk high
€1.66
52-wk low
€0.70
No. of employees
515
News stories
From web sources and news partners
About Alphamab Oncology
CEOTing Xu
Employees515
Founded2008
Headquarters-
SectorBiotechnology
Websitealphamabonc.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
123.40M
123.40M
135.62M
135.62M
Cost of goods sold
16.14M
16.14M
13.16M
13.16M
Cost of revenue
16.14M
16.14M
13.16M
13.16M
Research and development expenses
159.43M
159.43M
127.48M
127.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.79M
24.79M
17.06M
17.06M
Operating expense
184.22M
184.22M
144.54M
144.54M
Total operating expenses
200.37M
200.37M
157.70M
157.70M
Operating income
-76.97M
-76.97M
-22.08M
-22.08M
Other non operating income
5.05M
5.05M
155.50K
155.50K
EBT including unusual items
-67.76M
-67.76M
-20.23M
-20.23M
EBT excluding unusual items
-67.76M
-67.76M
-20.23M
-20.23M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-67.76M
-67.76M
-20.23M
-20.23M
Net profit margin
-54.91%
-54.91%
-14.92%
-14.92%
Earnings per share
-
-
-
-
Interest and investment income
7.75M
7.75M
6.09M
6.09M
Interest expense
-1.75M
-1.75M
-1.47M
-1.47M
Net interest expenses
6.00M
6.00M
4.62M
4.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
-61.19M
-61.19M
-6.52M
-6.52M
Gain or loss from assets sale
1.00K
1.00K
11.00K
11.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps